Nasopharyngeal carcinoma interventions

Xyz Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Xyz from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Nasopharyngeal carcinoma interventions On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Nasopharyngeal carcinoma interventions All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Nasopharyngeal carcinoma interventions
CDC on Nasopharyngeal carcinoma interventions
Nasopharyngeal carcinoma interventions in the news
Blogs on Nasopharyngeal carcinoma interventions
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Nasopharyngeal carcinoma interventions

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]

Overview

Radiotherapy:

Stage I and II:

• The mainstay of treatment for early stages of nasopharyngeal carcinoma is radiotherapy.
• Place of radiation:
  • both sides of neck
  • retropharyngeal nodes
• Dose:
  • Primary tumor and affected lymph nodes: 66–70 Gy
  • Uninvolved neck: 50 Gy

Indications

The mainstay of treatment for TT is medical therapy.